The researchers reported that 15% of all patients had nonsynonymous GBA1 variants vs. 6.4% of controls (OR 2.6), including 5 PD-related variants (9.3% in patients and 4.4% in controls) and 18 novel variants. The gene discussed is GBA1; the disease is Parkinson disease.